A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Medically reviewed by Sanja Jelic, MD Obstructive sleep apnea (OSA) is the most common form of sleep apnea.Central sleep apnea (CSA) is a less common but serious condition.Both OSA and CSA are ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

Incannex Healthcare Limited Sponsored ADR ( (IXHL) ) has provided an announcement.

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

New research shows long-term sleep problems may change gut bacteria, increasing inflammation and health risks beyond the ...